Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Best match
Most recent
PharmaTimes
1d
Richard Hopkins
NK:IO has appointed Richard Hopkins, an experienced biologics developer, as its new Chief Executive Officer.
PharmaTimes
2d
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Celltrion has announced groundbreaking results from a two-year study on dose escalation of subcutaneous infliximab (CT-P13 SC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
One Direction singer dies
Fox News interview
Exotic cat caught in suburb
Italy expands surrogacy ban
Felon voting rights upheld
Gets minimum 28 years
Disney to debut new pass
NH justice indicted
To return to Atlanta in 2028
Sentenced for cartel bribery
FDA halts Novavax trial
Cereal dyes protested
MI shooter drill settlement
To invest in nuclear reactors
Abortion group sues Florida
SpaceX sues CA regulators
AL voter roll purge blocked
To headline Atlanta rally
'Click to cancel' finalized
Ordered to pay $15 million
New cervical cancer regimen
GA election rules blocked
To settle US bribery probe
Synthetic nicotine pouches
$425M military aid for UKR
Allows EPA emissions rule
21K+ SUVs recalled
Had benign cyst removed
Feedback